Literature DB >> 27061817

The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms.

L A P Germoni1, P J Bremer2, I L Lamont1.   

Abstract

AIMS: Pseudomonas aeruginosa can secrete large amounts of alginate during chronic infections and this has been associated with high resistance to antibiotics. The major aim of this study was to investigate whether degradation of extracellular alginate by alginate lyase would increase the sensitivity of Ps. aeruginosa to gentamicin, an aminoglycoside antibiotic. METHODS AND
RESULTS: Degradation of alginate from Ps. aeruginosa was monitored using a spectrometric assay. Alginate lyase depolymerized alginate, but calcium and zinc cations at concentrations found in the cystic fibrosis lung reduced enzyme activity. Biofilms formed on agar were partially degraded by alginate lyase, but staining with crystal violet showed that the biomass of biofilms grown in liquid was not significantly affected by the enzyme. Viability testing showed that the sensitivity to gentamicin of biofilm bacteria and of bacteria released from biofilms was unaffected by alginate lyase.
CONCLUSIONS: Our results show that at least under the conditions used here alginate lyase does not affect gentamicin resistance of Ps. aeruginosa. SIGNIFICANCE AND IMPACT OF THE STUDY: Our study indicates that alginate does not contribute to resistance to gentamicin and so does not provide support for the concept of treating patients with alginate lyase in order to increase the antibiotic sensitivity of Ps. aeruginosa.
© 2016 The Society for Applied Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosa; alginate lyase; antibiotic sensitivity; bacterial alginate; biofilms; cystic fibrosis

Mesh:

Substances:

Year:  2016        PMID: 27061817     DOI: 10.1111/jam.13153

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  7 in total

Review 1.  Novel Treatment Strategies for Biofilm-Based Infections.

Authors:  Claudia Vuotto; Gianfranco Donelli
Journal:  Drugs       Date:  2019-10       Impact factor: 9.546

Review 2.  Bacterial Biofilm Inhibition: A Focused Review on Recent Therapeutic Strategies for Combating the Biofilm Mediated Infections.

Authors:  Ramanathan Srinivasan; Sivasubramanian Santhakumari; Pandurangan Poonguzhali; Mani Geetha; Madhu Dyavaiah; Lin Xiangmin
Journal:  Front Microbiol       Date:  2021-05-12       Impact factor: 5.640

3.  Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides.

Authors:  Lydia C Powell; Manon F Pritchard; Elaine L Ferguson; Kate A Powell; Shree U Patel; Phil D Rye; Stavroula-Melina Sakellakou; Niklaas J Buurma; Charles D Brilliant; Jack M Copping; Georgina E Menzies; Paul D Lewis; Katja E Hill; David W Thomas
Journal:  NPJ Biofilms Microbiomes       Date:  2018-06-29       Impact factor: 7.290

4.  Capsule Thickness, Not Biofilm Formation, Gives Rise to Mucoid Acinetobacter baumannii Phenotypes That are More Prevalent in Long-Term Infections: A Study of Clinical Isolates from a Hospital in China.

Authors:  Lihua Hu; Yue Shi; Qingye Xu; Linghong Zhang; Jintao He; Yan Jiang; Lilin Liu; Sebastian Leptihn; Yunsong Yu; Xiaoting Hua; Zhihui Zhou
Journal:  Infect Drug Resist       Date:  2020-01-09       Impact factor: 4.003

5.  Mucoid Acinetobacter baumannii enhances anti-phagocytosis through reducing C3b deposition.

Authors:  Xiaoxia Gong; Qian Zhao; Yifan Wu; Hongwei Zhou; Shuangyang Ding; Kui Zhu
Journal:  Front Med (Lausanne)       Date:  2022-09-15

6.  Elucidation of a Unique Pattern and the Role of Carbohydrate Binding Module of an Alginate Lyase.

Authors:  Fu Hu; Benwei Zhu; Qian Li; Heng Yin; Yun Sun; Zhong Yao; Dengming Ming
Journal:  Mar Drugs       Date:  2019-12-30       Impact factor: 5.118

7.  The efficacy of lyticase and β-glucosidase enzymes on biofilm degradation of Pseudomonas aeruginosa strains with different gene profiles.

Authors:  Maryam Banar; Mohammad Emaneini; Reza Beigverdi; Rima Fanaei Pirlar; Narges Node Farahani; Willem B van Leeuwen; Fereshteh Jabalameli
Journal:  BMC Microbiol       Date:  2019-12-12       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.